Clinical efficacy and safety of laparoscopic hybrid surgery for simultaneous resection of colorectal cancer liver metastases

doi:10.3748/wjg.v32.i32.119375

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 32

This Article

(19)

(17)

(0)

(10)

(168)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Aug 28, 2026; 32(32): 119375
Published online Aug 28, 2026. doi: 10.3748/wjg.v32.i32.119375

Table 1 Patient baseline data, n (%)/median (interquartile range)

Variable	TOS (n = 122)	LHS (n = 144)	P value
Gender			0.395
Male	70 (57.4)	90 (62.5)
Female	52 (42.6)	54 (37.5)
Age, years	60.00 (53.00, 67.00)	60.00 (51.25, 66.75)	0.813
Body mass index, kg/m²	23.44 (21.07, 25.36)	23.21 (21.49, 24.98)	0.943
Underlying conditions			0.570
Yes	72 (59.0)	80 (55.6)
No	50 (41.0)	64 (44.4)
Carcinoembryonic antigen at diagnosis, ng/mL			0.496
< 5	45 (36.9)	59 (41.0)
> 5	77 (47.5)	85 (59.0)
Cancer antigen 19-9 at diagnosis, U/mL			0.062
< 37	97 (79.5)	100 (69.4)
> 37	25 (20.5)	44 (30.6)
Preoperative chemotherapy			0.423
Yes	82 (67.2)	90 (62.5)
No	40 (30.8)	54 (37.5)
Preoperative targeted therapy			0.697
Yes	28 (23.0)	36 (25.0)
No	94 (77.0)	108 (75.0)
CRS score			0.289
1	34 (27.9)	50 (34.7)
2	53 (43.4)	57 (39.6)
3	31 (25.4)	33 (22.9)
4	4 (3.3)	4 (2.8)

TOS: Total open surgery; LHS: Laparoscopic hybrid surgery; CRS: Clinical Risk Score.

Full Size Table

Citation: Zhang TS, Zhu XM, Wen RB, Zhou LQ, Gong HF, Yu ED, Wang H, Li G, Zhou WP, Hao LQ, Yu GY, Zhang W. Clinical efficacy and safety of laparoscopic hybrid surgery for simultaneous resection of colorectal cancer liver metastases. World J Gastroenterol 2026; 32(32): 119375
URL: https://www.wjgnet.com/1007-9327/full/v32/i32/119375.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i32.119375

Zhang TS, Zhu XM, Wen RB, Zhou LQ, Gong HF, Yu ED, Wang H, Li G, Zhou WP, Hao LQ, Yu GY, Zhang W. Clinical efficacy and safety of laparoscopic hybrid surgery for simultaneous resection of colorectal cancer liver metastases. World J Gastroenterol 2026; 32(32): 119375 [DOI: 10.3748/wjg.v32.i32.119375]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.